Medical News

RSS

DASH formable absorbent retractor improves patient safety

The risk of retaining a foreign object during surgery is well documented. Efforts to reduce its incidence may include the use of fewer laparotomy pads. Now there is a clinically proven device that is designed to improve surgical outcomes -- The DASH™ (Disposable Absorbent Secure Hold) formable absorbent retractor, addresses the challenges of unintentional soft tissue trauma and retained foreign objects after surgery, enhancing patient safety.

13 Jan 2010

Monsanto and Stokes Bio announce licensing agreement and R&D collaboration

Monsanto Company and Limerick-based biotechnology firm, Stokes Bio Limited, announced today that they have entered into a licensing agreement and R&D collaboration, which is expected to help accelerate the pace of new advancements in plant breeding.

13 Jan 2010

New Jersey to legalize medical marijuana

The New York Times: "The New Jersey Legislature approved a measure on Monday that would make the state the 14th in the nation, but one of the few on the East Coast, to legalize the use of marijuana to help patients with chronic illnesses.

13 Jan 2010

ACP issues position paper to guide ethical relationships among patients, physicians and caregivers

The American College of Physicians (ACP) has issued a position paper to guide ethical relationships among patients, physicians, and caregivers.

13 Jan 2010

Autologous stem cell transplantation may benefit breast cancer patients

Compared to conventional chemotherapy, autologous stem cell transplantation can extend "event-free survival" for breast cancer patients. Clinical trials provide proof of this for breast cancer with and without distant metastases. However, there are indications that this type of stem cell transplantation can more frequently give rise to severe complications affecting almost all organ systems. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 December 2009.

13 Jan 2010

Pathway Genomics launches new campaign to highlight the benefits of genetic testing services

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, today launched a new campaign designed to facilitate discussions around consumer genetic testing services. Called ‘DNA Conversation Starters,’ Pathway will address a range of topics about genetic testing, further educating members of the media, the genetic testing community, and consumers about the benefits of genetic testing services and the depth of information obtained from Pathway’s Genetic Health and Ancestry tests.

13 Jan 2010

Study reveals new insights about stress in work-life balance

As many as 50 per cent of people bring their work home with them regularly, according to new research out of the University of Toronto that describes the stress associated with work-life balance and the factors that predict it.

13 Jan 2010

ProtoKinetix’ AAGP raises hope for treatment of diabetes

Independent studies done by universities and corporations have illustrated a remarkable increase in the yield of viable stem cells after cryopreservation using AAGP™ in the freeze-thaw process. One future approach to increasing diabetics’ insulin production is related to an ability to convert their stem cells into islet cells for transplantation. The feasibility of this procedure is dependent upon the amount of functioning islet cells that can be derived from the patient’s stem cells. This is where AAGP™ can make a very beneficial contribution.

13 Jan 2010

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

13 Jan 2010

LUMEN 2010 analyzes strategies to reduce rising mortality in women with cardiovascular disease

It is no longer a theory. Percutaneous coronary intervention (PCI) or coronary angioplasty is the best treatment for a person presenting with STEMI (ST- elevation myocardial infarction), a heart attack caused by complete obstruction of a coronary artery.

13 Jan 2010

Lawmakers face political challenges as they return to health overhaul chores

During the holiday vacation, some Democratic lawmakers appeared to waver on health reform, faced with "tepid public support" for their proposal and "mounting electoral angst for the party," Politico reports. "But through it all — and through what is expected to be multiple near-death experiences for the health care bill in coming weeks — White House and congressional leaders plan to beat back the temptation of 'no' with a hardball argument: Democrats already voted 'yes.' And it would be politically disastrous to flip-flop now" (Brown, 1/12).

13 Jan 2010

Natural Magic' herbal skin care line to feature in VIP gift bags at Golden Globes events

California based Natural Magic announced today that its unique herbal skin care line will feature in VIP gift bags at exclusive Golden Globes events. The company is working with red carpet experts Secret Room Events, known throughout Hollywood for producing unique events that are attended by nominees, presenters, celebrities, stylists, and media.

13 Jan 2010

BARDA invites Aeolus Pharmaceuticals to submit proposal for development of AEOL 10150

Aeolus Pharmaceuticals, Inc. announced today that after review of the Company’s white paper on development of AEOL-10150 as a countermeasure for the lung effects of acute radiation syndrome, the Biomedical Advanced Research and Development Authority (BARDA) Division of Chemical, Radiological and Nuclear (CBRN) Countermeasures has informed the Company that, after careful analysis and consideration, it has invited Aeolus to submit a full proposal for a contract to develop AEOL 10150 from its current level of technical readiness to FDA approval.

13 Jan 2010

Studies show naturally-occurring protein in humans restores motor function in rats after a stroke

People with impaired mobility after a stroke soon may have a therapy that restores limb function long after the injury, if a supplemental protein works as well in humans as it does in paralyzed rats.

13 Jan 2010

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

moksha8 and BioCryst today announced that moksha8 has been granted approval from COFEPRIS (The Federal Commission for the Protection against Sanitary Risk) in Mexico for the importation and use of peramivir in patients with influenza associated with the 2009 H1N1 influenza A strain.

13 Jan 2010

Research reveals how cancers shield themselves from immune attack

Melanoma, if not detected in its early stages, transforms into a highly deadly, treatment-resistant cancer. Although the immune system initially responds to melanoma and mounts anti-tumor attacks, these assaults are generally ineffective, allowing more advanced melanomas to win the battle and spread beyond the primary site.

13 Jan 2010

New book provides tools to control mind/body connections

Brain Drain (ISBN: 0984196307; 978-0984196302) authored by Charles F. Glassman, M.D., FACP, is a powerful new book that teaches people how to break free of their brains' automatic responses through understanding and controlling their mind/body connections.

13 Jan 2010

Masimo announces strategic investment totaling $3.5M in SEDLine

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, today announced a strategic investment totaling $3.5 million in SEDLine, Inc., a newly-formed private company that was formerly operated by Hospira, Inc.

13 Jan 2010

Blood test may be effective for diagnosing lung cancer

Of the nearly 150,000 abnormal chest X-rays performed each year in the United States, 25 percent of patients will display only benign lung pathologies on further surgical examination.

13 Jan 2010

Kapa Biosystems signs non-exclusive North American distribution agreement with VWR International

Kapa Biosystems and VWR International, LLC announced today that they have entered into a non-exclusive North American distribution agreement for Kapa Biosystems' line of next-generation PCR reagents.

13 Jan 2010

Medical News

DASH formable absorbent retractor improves patient safety

Monsanto and Stokes Bio announce licensing agreement and R&D collaboration

New Jersey to legalize medical marijuana

ACP issues position paper to guide ethical relationships among patients, physicians and caregivers

Autologous stem cell transplantation may benefit breast cancer patients

Pathway Genomics launches new campaign to highlight the benefits of genetic testing services

Study reveals new insights about stress in work-life balance

ProtoKinetix’ AAGP raises hope for treatment of diabetes

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

LUMEN 2010 analyzes strategies to reduce rising mortality in women with cardiovascular disease

Lawmakers face political challenges as they return to health overhaul chores

Natural Magic' herbal skin care line to feature in VIP gift bags at Golden Globes events

BARDA invites Aeolus Pharmaceuticals to submit proposal for development of AEOL 10150

Studies show naturally-occurring protein in humans restores motor function in rats after a stroke

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

Research reveals how cancers shield themselves from immune attack

New book provides tools to control mind/body connections

Masimo announces strategic investment totaling $3.5M in SEDLine

Blood test may be effective for diagnosing lung cancer

Kapa Biosystems signs non-exclusive North American distribution agreement with VWR International

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News